期刊簡介預(yù)計審稿時間： 12周，或約稿

Hematological Oncology considers for publication articles dealing with experimental and clinical aspects of neoplastic diseases of the hemopoietic and lymphoid systems and relevant related matters. Translational studies applying basic science to clinical issues are particularly welcomed. Manuscripts dealing with the following areas are encouraged:

-Clinical practice and management of hematological neoplasia, including: acute and chronic leukemias, malignant lymphomas, myeloproliferative disorders

-Diagnostic investigations, including imaging and laboratory assays

-Epidemiology, pathology and pathobiology of hematological neoplasia of hematological diseases

-Therapeutic issues including Phase 1, 2 or 3 trials as well as allogeneic and autologous stem cell transplantation studies

-Aspects of the cell biology, molecular biology, molecular genetics and cytogenetics of normal or diseased hematopoeisis and lymphopoiesis, including stem cells and cytokines and other regulatory systems.

Concise, topical review material is welcomed, especially if it makes new concepts and ideas accessible to a wider community. Proposals for review material may be discussed with the Editor-in-Chief. Collections of case material and case reports will be considered only if they have broader scientific or clinical relevance.

《血液腫瘤學》雜志刊登的文章涉及造血和淋巴系統(tǒng)腫瘤疾病的實驗和臨床方面以及相關(guān)事宜。特別歡迎將基礎(chǔ)科學應(yīng)用于臨床問題的轉(zhuǎn)化研究。鼓勵投稿涉及以下領(lǐng)域的稿件：

-血液腫瘤的臨床實踐和管理，包括：急性和慢性白血病、惡性淋巴瘤、骨髓增生性疾病

-診斷研究，包括影像學和實驗室檢測

-血液疾病的血液腫瘤的流行病學、病理學和病理生物學

-治療問題，包括 1、2 或 3 期試驗以及同種異體和自體干細胞移植研究

-正?；蚧疾≡煅土馨图毎募毎飳W、分子生物學、分子遺傳學和細胞遺傳學方面，包括干細胞和細胞因子以及其他調(diào)節(jié)系統(tǒng)。

歡迎簡明扼要、主題鮮明的綜述材料，尤其是如果它能讓更廣泛的社區(qū)能夠接觸到新的概念和想法?？梢耘c主編討論評論材料的提案。只有具有更廣泛的科學或臨床相關(guān)性的病例材料和病例報告集合才會被考慮。

《Hematological Oncology》(血液腫瘤學)編輯部通訊方式為JOHN WILEY & SONS LTD, THE ATRIUM, SOUTHERN GATE, CHICHESTER, ENGLAND, W SUSSEX, PO19 8SQ。如果您需要協(xié)助投稿或潤稿服務(wù)，您可以咨詢我們的客服老師。我們專注于期刊咨詢服務(wù)十年，熟悉發(fā)表政策，可為您提供一對一投稿指導(dǎo)，避免您在投稿時頻繁碰壁，節(jié)省您的寶貴時間，有效提升發(fā)表機率，確保SCI檢索（檢索不了全額退款）。我們視信譽為生命，多方面確保文章安全保密，在任何情況下都不會泄露您的個人信息或稿件內(nèi)容。